Oasis Labs

Name: Oasis Labs
Brand: Oasis Labs

Building cutting-edge technologies in AI, privacy and decentralization

Est 2018|Valuation $170M|Raised $48M|14 Ref Customers

LinkedIn 4K|Website|FTEs 22|HQ San Francisco, California, US

MarketsData Privacy Management

Published Oct 15, 2026

01Common complaints

- When independent, broad customer review coverage (e.g., G2, Capterra) is required as part of vendor selection. - When procurement requires publicly available SOC 2 or ISO 27001 certification evidence prior to procurement. - When the primary need is for distributable synthetic datasets for many downstream consumers; synthetic-data-focused vendors may be operationally simpler for that use case. - When the use case cannot tolerate differential privacy noise (for example, regulatory reporting requiring deterministic values or analytics on very small cohorts where noise overwhelms signal). - When comprehensive support for advanced or proprietary SQL dialect features is required and cannot be validated in an initial pilot.

Deal disqualifiers (poor fit)

Requirement for exact, deterministic answers at row level or highly precise aggregate values
Organizations unwilling to invest in differential privacy education and change management
Organizations that require publicly documented SOC 2 / ISO certifications prior to procurement and cannot accept documentation provided under NDA

Publicly acknowledged limitations

Public materials list supported operations such as COUNT, SUM, AVG, VAR, STDDEV, PERCENTILE, MIN, MAX, and JOINs across shared tables, but do not provide comprehensive coverage of complex SQL feature support.
Deeper documentation on performance characteristics, operational constraints, and detailed privacy–utility trade-offs is limited in the public materials reviewed.

Roadmap visibility

No clear, dated product roadmap was found in publicly available sources captured during this research pass.

Brand/name ambiguity risk (practical limitation)

The name "Oasis Labs" is used by multiple unrelated entities (consumer peptides/supplements, other startups). This creates practical risks such as procurement confusion, misdirected security reviews, and misinterpretation of online reviews.

02Why they buy

Observed strengths (based on available evidence)

Differential privacy is applied at the SQL layer through query rewriting and enforcement mechanisms, according to vendor materials.
The concept of tracking privacy budgets aligns with standard approaches to managing cumulative privacy loss in differential privacy systems.
The vendor emphasizes healthcare use cases and references HIPAA-related claims and a named healthcare testimonial.

Where competitors may have advantages

Other vendors may provide more transparent security documentation, broader customer review presence, clearer pricing, and more extensive documentation and community resources.

03Field reports

Review-platform reality check (G2/Capterra/TrustRadius)

No clear G2 or Capterra product profile for the vendor was identified in this research pass. No TrustRadius profile was found for the same target company name.

Implication: vendor-provided references, technical pilots, and direct validation will likely be important to evaluate the product in the absence of broad review-platform coverage.

Vendor-published testimonial (healthcare)

The product page includes a vendor-published testimonial from a healthcare organization innovation group, attributed to senior clinical leadership. The testimonial indicates that the healthcare organization has worked with the vendor to adopt differential-privacy approaches for healthcare data. This testimonial is vendor-published and does not include quantified metrics such as time saved, reduction in privacy risk, or dataset counts; procurement teams should request detailed references and measurable outcomes.

Community/Social discussion signals

Community discussions on platforms such as Reddit include skepticism about the visibility and current activity level of some related projects. One community comment observed that the company's site highlights collaborations but lacks linked sources or recent updates; this reflects community perception rather than a verified product assessment.

Name-collision reviews (NOT the same company)

Consumer-review sites contain reviews for other businesses using similar names (for example, consumer peptide/supplement retailers). These consumer reviews are not relevant to the privacy-focused vendor but may cause confusion for buyers searching online.

Example consumer-review excerpts relate to shipping and customer service for unrelated businesses and should not be treated as evidence about the privacy-focused vendor.

Vendor-published healthcare reference

Evidence: testimonial on the PrivateSQL product page.
Quantified metrics: not provided in the public material.

Critical evaluation: this is a named reference in vendor materials and a plausible lead for procurement teams, but organizations should request a detailed case study describing scope (datasets and PHI types), differential privacy parameter settings, before/after risk posture, and operational overhead.

University-affiliated hospital mention (historical press coverage)

Earlier press coverage describes prior technology work and tests conducted with a university-affiliated hospital on secure data storage and use for machine learning research. This material is directional but dates from earlier company initiatives and may not reflect the current product offering or commercial maturity.

04Best fit

Company sizes

Mid-sized to large organizations (mid-market to enterprise) with dedicated security/privacy and data platform functions.

Industries / verticals

Healthcare (explicit references in marketing materials and a vendor-published healthcare testimonial)
Financial services and insurance (common users of differential privacy approaches)
Any sector requiring aggregated analytics on sensitive data

Roles/personas

Decision-makers: Chief Information Security Officer, Chief Privacy Officer, VP Data/Analytics, Head of Data Governance
Primary users: data analysts, data scientists, data engineers, and privacy engineers

Qualification criteria (good fit)

Need to enable analytics on sensitive datasets without releasing raw, row-level data
Willingness to accept and manage DP noise and accuracy trade-offs
Governance maturity to define privacy budgets and enforce policies

05The pitch

What the product does (core value proposition)

Oasis Labs provides tools for privacy-preserving data analysis. Its primary product, PrivateSQL, is presented as a differential-privacy layer that rewrites and executes SQL queries to reduce the risk of exposing sensitive records. The vendor describes features intended to automate differential privacy parameter application, apply enforcement mechanisms to block queries that would expose sensitive records, and track privacy budgets to manage cumulative privacy loss. This report focuses on Oasis Labs and notes the potential for buyer confusion because unrelated businesses use similar names.

Target market and positioning

The product is positioned toward: - Regulated data environments (healthcare is referenced via HIPAA-related claims and a vendor-published healthcare testimonial). - Data-sharing and analytics collaboration scenarios where teams or partners query sensitive datasets. - Organizations seeking differential privacy applied to SQL analytics without building internal differential-privacy expertise from scratch. Marketing materials emphasize concepts such as privacy by design and the formal properties of differential privacy; procurement teams should validate these claims against technical documentation and pilot results.

Get a comprehensive analysis of Oasis Labs including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →